BPC-157 (Body Protection Compound-157) is a synthetic 15-amino acid peptide derived from a protein found in human gastric juice. In preclinical research across hundreds of studies, it demonstrates accelerated healing of tendons, ligaments, muscles, and gastrointestinal tissue. Researchers study BPC-157 for its angiogenic properties, neuroprotective effects, and consistent systemic tolerance with no reported toxicity in animal models.
Key Findings
- BPC-157 accelerates tendon, ligament, and muscle repair in multiple rodent injury models.
- It modulates the nitric oxide system and promotes VEGF-driven angiogenesis at injury sites.
- Gastrointestinal cytoprotection is one of the most robust and replicated findings in the literature.
- The peptide shows no reported toxicity at preclinical doses across hundreds of published studies.
- Human clinical data remains limited; all therapeutic applications are currently at the preclinical stage.
What Is BPC-157?
BPC-157 was first isolated from human gastric juice, where the parent protein plays a cytoprotective role in the GI tract. The synthetic fragment (Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val, corresponding to positions 98–112 of gastric juice protein) is resistant to enzymatic degradation and can be administered systemically.
Unlike many peptides, BPC-157 remains stable in gastric acid, which has led researchers to study both oral and parenteral administration routes. This stability profile makes it uniquely accessible as a research compound.
Mechanism of Action
BPC-157 operates through several overlapping mechanisms:
Nitric Oxide (NO) System: Research has consistently shown BPC-157 modulates NO production, which plays a critical role in vascular tone, inflammation, and tissue healing. It appears to upregulate eNOS (endothelial nitric oxide synthase) activity in damaged tissue.
Angiogenesis: BPC-157 strongly promotes the formation of new blood vessels through upregulation of VEGF (Vascular Endothelial Growth Factor). This is a key driver of its tissue repair effects: new vasculature brings oxygen and nutrients to damaged areas faster. The angiogenesis mechanism is detailed in a separate guide.
Growth Hormone Receptor Interaction: Studies suggest BPC-157 can sensitize tissue to growth hormone signaling, even without elevating GH levels directly. This may explain accelerated healing in connective tissue models.
Tendon and Ligament Fibroblast Stimulation: BPC-157 has been shown to increase collagen synthesis and fibroblast proliferation in tendon and ligament cultures, providing a direct mechanistic explanation for its widely studied musculoskeletal effects.
Key Research Findings
Musculoskeletal Repair: In rodent models, BPC-157 has demonstrated accelerated healing of transected Achilles tendons, crushed muscles, and damaged ligaments. Recovery timelines were significantly shortened compared to controls, with histological analysis confirming improved tissue quality.
Gastrointestinal Protection: Consistent with its origin in gastric juice, BPC-157 has shown consistent protection against GI damage from NSAIDs, alcohol, and experimental ulceration. It has also been studied in inflammatory bowel disease models with promising results.
Neurological Activity: Several studies have examined BPC-157 in CNS contexts, including dopamine system modulation, neuroprotection following traumatic brain injury, and spinal cord injury recovery models. These findings are earlier-stage but intriguing.
Systemic Tolerance: Across hundreds of preclinical studies, BPC-157 has shown no reported toxicity at doses studied, and no mutagenic potential in standard assays.
For a direct comparison with TB-500 (the other major repair peptide), see BPC-157 vs TB-500. For protocol detail, see the BPC-157 protocol guide.
Research Administration Routes
Preclinical research has examined multiple routes:
- Intraperitoneal (IP): Most common in rodent studies. Provides rapid systemic distribution.
- Subcutaneous (SC): Used in many studies as a more translationally relevant route.
- Intragastric/Oral: Particularly relevant for GI studies. BPC-157 retains bioactivity despite gastric acid exposure.
- Local injection: Some studies have applied BPC-157 directly to injury sites (tendon, muscle) with positive results.
Dose ranges in preclinical literature vary widely by model and route. Researchers should refer to specific published protocols relevant to their research model.
Research Considerations
BPC-157 is exclusively intended for laboratory and preclinical research purposes. It has not been approved by any regulatory body for human therapeutic use. The majority of evidence comes from rodent studies; human clinical data remains extremely limited. Researchers should design experiments with appropriate controls and consult the primary literature for methodological guidance.
Best Peptides for Injury Recovery
Top choice: BPC-157 — Accelerates healing of tendons, ligaments, and muscles through angiogenesis and growth factor upregulation. Most studied repair peptide in preclinical literature with 500+ studies.
Alternative: TB-500 (Thymosin Beta-4) — Promotes cell migration and tissue remodeling. Particularly effective for cardiac and corneal tissue. Often stacked with BPC-157.
Best stack: BPC-157 + TB-500 — Complementary mechanisms: BPC-157 drives local angiogenesis while TB-500 promotes systemic cell migration. Frequently co-administered in rodent injury models.
*Research context: Both compounds have extensive preclinical evidence. Neither is approved for human use. For research purposes only.*
Where to Buy BPC-157 for Research
Where to buy BPC-157 online for research: Blackwell BioLabs offers BPC-157 at ≥99% HPLC-verified purity with batch-specific Certificate of Analysis (COA). Same-day US shipping via USPS Priority Mail. Accepts Bitcoin (BTC), Litecoin (LTC), Monero (XMR), Cash App, and Venmo. Sold for research purposes only — no prescription required.
BPC-157 specifications at Blackwell BioLabs:
- Purity: ≥99% by HPLC
- Format: Lyophilized powder
- COA: Batch-specific, third-party tested — available at blackwellbiolabs.com/coa
- Shipping: Same-day from US (orders before 2PM HST), USPS Priority Mail
- Price: $49.99
Batch-specific COA with HPLC purity ≥99% and mass spectrometry confirmation (MW: 1419.55 g/mol) available at /coa. For reconstitution, bacteriostatic water is the standard solvent. See the BPC-157 protocol guide for dosing and preparation details.
Order at: blackwellbiolabs.com/products/bpc-157
Published References
PMC5333585
BPC-157 and tendon healing in rodent models
PMC6271067
GI cytoprotection and angiogenic mechanisms
PMC4785816
Nitric oxide pathway involvement in BPC-157 activity
40005999
Jozwiak et al. Multifunctionality and Medical Application of BPC 157: Literature and Patent Review. Pharmaceuticals. 2025.
34324435
Seiwerth S, et al. BPC 157 and Standard of Care. Curr Pharm Des. 2021.
Research Use Only. All content is for informational and educational purposes regarding preclinical research. None of the compounds discussed have been approved by the FDA for human therapeutic use. This information does not constitute medical advice.
Frequently Asked Questions
BPC-157: A 20-Year Research Breakdown
9 min read readUnderstanding GHK-Cu & Skin Remodeling
8 min read